Past or Current Smoking Predicts End-Organ Damage in Systemic Lupus Erythematosus
Researchers compared the association of smoking history and pack-year exposure with rate of end-organ damage in systemic lupus erythematosus.
Systemic Lupus Erythematosus
SYSTEMIC LUPUS ERYTHEMATOSUS
-
-
Physical Inactivity Linked to Risk for Incident Depression in Patients With SLE
Researchers studied the effect of physical activity and risk for incident depression in patients with systemic lupus erythematosus. -
Mortality Highest for Asians, Hispanic/Latinos With Lupus
Standardized mortality ratios of observed-to-expected deaths are increased for patients with SLE and are especially high for Asians and Hispanic/Latinos. -
Study Focuses on Incidence and Disease Course of COVID-19 in Patients With Systemic Lupus Erythematosus
Study authors evaluated the incidence of SARS-CoV-2 infections in patients with systemic lupus erythematosus and the effect of treatment discontinuation on disease activity. -
Women With SLE Are at Increased Risk for Osteoporosis and Osteoporotic Fractures
Researchers assessed the prevalence and risk factors for osteoporosis in patients with systemic lupus erythematosus. -
2019 ACR/EULAR Score Predicts Lupus Nephritis, Renal Flare Risk
Study findings support the utility of the 2019 EULAR/ACR classification in everyday nephrology clinical practice. -
Significant Association Found Between Endometriosis and Systemic Lupus Erythematosus
Researchers examined the association between endometriosis and the risk for systemic lupus erythematosus. -
Intensified B-Cell Depletion Protocol Effective in Lupus Nephritis
Despite the disappointing results of randomized controlled trials such as LUNAR, targeting B cells remains an attractive option in patients with lupus nephritis. -
Predictors of Kidney Failure in Systemic Lupus Erythematosus Identified
Over 20 years, 8.4% of patients with lupus developed end-stage kidney disease, a study found. -
Case Study: Rheumatic Disease Presents With Rare Cardiac Manifestation
Case study of a woman with a rare cardiac manifestation of a rheumatic disease.
LATEST NEWS
Increase in Hydroxychloroquine-Related Adverse Reactions in 2020
The number of ADRs associated with hydroxychloroquine and chloroquine more than doubled in 2020 compared with 2018 and 2019.
Voclosporin Approved for Active Lupus Nephritis
The approval was based on data from the pivotal phase 3 AURORA and phase 2 AURA-LV studies.
Case Report: Tuberculous Arthritis of Ankle Joint Mimics RA in Patient With Lupus Nephritis
In this case study, the authors highlighted the importance of tuberculous arthritis in the differential diagnoses of patients with persistent ankle swelling.
Text Mining of Electronic Health Records Can Accurately Identify Systemic Lupus Erythematosus
Researchers presented a text mining algorithm to assess the diagnosis and characteristics of patients with systemic lupus erythematosus.
Kidney Disease in SLE Possible Despite Low-Level Proteinuria
Based on new findings from a study of patients with systemic lupus erythematosus, investigators suggest revising current guidelines to expand kidney biopsy indications to include isolated proteinuria of any grade.
Study Estimates Prevalence of Lupus in the United States
The estimated prevalence of systemic lupus erythematosus (SLE) in the United States is 72.8/100,000.
Two-Thirds of Patients With Lupus Likely to Take COVID-19 Vaccine
A survey from the Lupus Research Alliance announced that two-thirds of people with lupus are willing to receive a COVID-19 vaccine.
Identifying Risk Factors for Osteonecrosis in Patients With Systemic Lupus Erythematosus
Researchers identified predictors of osteonecrosis in patients with systemic lupus erythematosus.
Hydroxychloroquine Levels Linked to Thrombosis Risk in Lupus
For patients with SLE lower hydroxychloroquine blood levels are associated with a higher risk for thrombotic events.
Rituximab Plus Cyclophosphamide Followed by Belimumab Safe for Refractory Lupus Nephritis Treatment
Researchers evaluated the safety, mechanism of action, and preliminary efficacy of rituximab and cyclophosphamide followed by belimumab in the treatment of refractory lupus nephritis.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Systemic Lupus Erythematosus
